VeriMomIst spondias mombin pulp extract in der Schwangerschaft sicher?
No harmonised CLP reproductive classification (no H361/H360) or SCCS/CIR safety assessment was identified for Spondias mombin pulp extract. Peer‑reviewed and regulatory sources do not report human teratogenicity or animal reproductive toxicity for this botanical extract; therefore default no‑hazard is applied (h=0). No mechanism of reproductive toxicity is described in available literature (m=0). No data indicate significant systemic absorption from topical cosmetic use; absent specific absorption data, exposure is considered negligible for adults (e=0). Sources searched: ECHA Annex VI (C&L), PubMed, CIR, CosIng, PubChem, EWG.
Pregnancy-safe products containing spondias mombin pulp extract
Related ingredients
Frequently asked questions
- Ist spondias mombin pulp extract in der Schwangerschaft sicher?
- No harmonised CLP reproductive classification (no H361/H360) or SCCS/CIR safety assessment was identified for Spondias mombin pulp extract. Peer‑reviewed and regulatory sources do not report human teratogenicity or animal reproductive toxicity for this botanical extract; therefore default no‑hazard is applied (h=0). No mechanism of reproductive toxicity is described in available literature (m=0). No data indicate significant systemic absorption from topical cosmetic use; absent specific absorption data, exposure is considered negligible for adults (e=0). Sources searched: ECHA Annex VI (C&L), PubMed, CIR, CosIng, PubChem, EWG.
- Ist spondias mombin pulp extract während des Stillens sicher?
- No data indicating reproductive or lactation-specific hazards, no harmonised classification, and no published evidence of transfer into milk or lactation toxicity for Spondias mombin pulp extract. Mechanistic or absorption evidence is lacking; therefore hazard and mechanism scores are 0. Topical cosmetic use is expected to give negligible maternal systemic exposure (e=0) absent formulation/PK data.
- Ist spondias mombin pulp extract sicher für Babyhaut?
- No infant‑specific reproductive or developmental toxicity data were found. Hazard and mechanism remain 0 because no evidence indicates developmental or endocrine activity in vivo. Exposure score increased to 1 for baby skin because infant skin has higher permeability and surface‑area‑to‑weight, so measurable percutaneous absorption cannot be excluded even if adult systemic exposure is expected to be negligible.
- Wie bewertet VeriMom spondias mombin pulp extract?
- VeriMom bewertet spondias mombin pulp extract mit 100/100 (keine bekannten Risiken) basierend auf EU CosIng, ECHA-Klassifizierungen und PubMed-Studien.
- Was sind schwangerschaftssichere Alternativen zu spondias mombin pulp extract?
- Siehe unsere kuratierte Liste der schwangerschaftssicheren Alternativen zu spondias mombin pulp extract basierend auf ähnlicher Funktion.
Prüfe jede Zutatenliste in 2 Sekunden
Lade VeriMom kostenlos — scanne jedes Produkt und sieh sofort die Schwangerschafts-Sicherheitsbewertung.
Medizinischer Haftungsausschluss
Diese Informationen dienen ausschließlich Bildungszwecken und stellen keine medizinische Beratung dar. Sicherheitsbewertungen basieren auf öffentlich zugänglichen Daten und spiegeln möglicherweise nicht alle Risiken wider. Konsultieren Sie immer Ihren Arzt, bevor Sie ein Produkt während der Schwangerschaft oder Stillzeit verwenden.